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ABSTRACT : Federal legislation that has been introduced to amend the Social Security Act in order to 
provide for coverage of cognitive pharmacist services under the Medicare program in medically underserved 
communities.  In the rural state of Arkansas this legislation would be well-received because a large portion of 
the state meets the criteria of a health professional shortage area.  Considering the growing interest of using 
telecommunications as an alternative means of delivering healthcare services to medically underserved rural 
areas, a pharmacist-staffed consumer-oriented drug information service was explored.  Over a 5-day period, 
473 face-to-face consumer surveys were conducted in pharmacy and non-pharmacy settings in an urban cluster 
population center that serves the surrounding rural area.  The survey was designed to determine whether or not 
consumers had a perceived need for a drug information service that was independent from and supplemental to 
services provided by their pharmacist.  Results reveal that 71% of participants surveyed did not perceive a need 
for medication information that was supplemental to that provided by their pharmacist.  When queried regarding 
the likelihood of using a drug information service if one was available their response was neutral, and they 
became less likely if a fee was associated with the service.  While the results are not conclusive and cannot be 
generalized as to whether a consumer-oriented drug information service would contribute to improving patient 
care, the survey suggests that this telepharmacy service is not perceived as being needed by the public. 
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I. INTRODUCTION 
Under federal law in the United States, despite their extensive education and training on the use 
of drug therapy, pharmacists are not recognized as healthcare providers.  While strides have been made 
to recognize pharmacists at the state level, this lack of provider status has severely limited pharmacists’ 
formal contribution to improving patient care.  On March 11, 2014, H.R. 4190 was introduced in the 
United States House of Representatives, legislation that would amend the Social Security Act to provide 
for coverage of cognitive (non-drug product) pharmacist services under the Medicare program in 
medically underserved communities (i.e. settings located in a health professional shortage area, medically 
underserved area, or medically underserved population).[1] 
Arkansas, situated in the southern United States, is a state with 75 counties that has a largely 
rural population (45%).  All or parts of 73 counties have been identified as medically underserved, while 
55 counties have officially designated health professional shortage areas.[2]  Recent statistics show there 
are 867 residents in Arkansas for every one primary care doctor, whereas in the U.S. overall there are 631 
residents for every one primary care doctor.[3]  In contrast, in Arkansas there are approximately 4,500 
pharmacists represented in all 75 counties which equates to a favorable 658 residents for every one 
pharmacist.[4]  Clearly, legislation that affords pharmacists provider status coupled with the size and 
distribution of the pharmacist workforce could help meet the needs of patients in rural Arkansas. 
As a means of delivering pharmacy services in medically underserved rural areas, some states 
have seen the development and implementation of telepharmacy services.  While the provision of 
pharmacy services via telecommunications has been described to include a variety of clinical and 
dispensing functions, in Arkansas it has principally revolved around remote order entry with drug 
regimen review in a hospital setting.[5,6]  One service that would be readily adaptable to a telepharmacy 
application and could be provided on a large scale are pharmacist-based drug information services. 
Drug information centers have been a staple in pharmacy practice since their inception.  
However, their traditional role has been principally focused on serving healthcare providers, almost to 
the exclusion of consumers.  The objective of this survey was to explore the perceived need for a 
consumer-oriented drug information telepharmacy service that is unrelated to pharmacy dispensing 
services in rural Arkansas. 
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II. METHODS 
We conducted face-to-face consumer surveys over a 5-day period in an urban cluster population 
center of approximately 21,000 inhabitants which serves as the economic epicenter for the surrounding 
rural area.[7]  Survey participants were recruited from both pharmacy and non-pharmacy settings, 
including six chain pharmacies, five independent pharmacies, and two non-pharmacy commercial 
establishments.  All unique respondent identifiers were purged from the aggregate data upon completion 
of data collection and prior to analysis.  This survey received an exempt status from the Harding 
University institutional review board.  Participation was voluntary without inducement and informed 
consent was given. 
Upon agreeing to participate in the survey, the purpose of a consumer-oriented drug information 
service was first described to each respondent as:  “The purpose of a drug information service is to 
answer your medication-related questions by providing you with objective, unbiased information in an 
effort to promote safe and cost-effective medication use.”  Then, participants were administered a 2-3 
minute survey designed to determine whether or not consumers had a perceived need for a drug 
information service that was independent from and supplemental to services provided by their 
pharmacist.  The survey instrument consisted of a combination of five closed-ended, Likert scaled, and 
multiple-choice questions.  On a scale of 1 to 5, with 1 being highly-likely and 5 being highly-unlikely, 
participants were asked regarding the probability that they would use a consumer-oriented drug 
information service if one were available, and separately the probability that they would use the service if 
a fee was involved.  Finally, the survey collected information on the types of drug-related questions the 
consumer would most commonly have, as well as the preferred method by which the consumer could 
pose and receive responses to information requests.  Descriptive statistics were compiled expressing 
results as percentages for each question in the survey. 
 
III. RESULTS 
A total of 473 participants provided evaluable responses to the survey (Table 1).  The total 
number of surveys completed was nearly evenly distributed across pharmacy (n=252, 53%) and non-
pharmacy (n=221, 47%) settings.  However, more individuals participated in the survey from a chain 
pharmacy setting (179, 71%) when compared to an independent pharmacy setting (73, 29%). 
 
Table 1.  Perceived Need for Consumer-Oriented Drug Information 
Survey Setting # Information Needed 
Respondents Yes No 
All Settings Combined 473 135 (29%) 338 (71%) 
    Pharmacy 252 64 (25%) 188 (75%) 
     Independent 73 17 (23%) 56 (77%) 
     Chain Drugstore 179 47 (26%) 132 (73%) 
    Non-Pharmacy 221* 71 (32%) 150 (68%) 
*Two participants in a non-pharmacy setting did not answer this question 
 
When asked “Do you have a need personally for information about your medication that would 
supplement information provided by your pharmacist?”, overall only 29% responded in the affirmative 
with the vast majority (71%) indicating they did not have a personal need.  When responses were 
separated according to survey setting (see Table 1), there was a slightly greater perceived need by 
participants queried in a non-pharmacy setting (32%) versus those asked inside a pharmacy (25%). 
 
Table 2.  Consumer's Likelihood of Using a Drug Information Center 
 (Scaled Response: 1 = Highly-Likely to 5 = Highly Unlikely) 
Survey Setting # Respondents 
Mean 
Response   
All Settings Combined 472 2.9 
  
     Pharmacy 249 3.0 
  
     Independent 72 2.9 
  
     Chain Drugstore 177 3.1 
  
     Non-Pharmacy 223 2.8 
  
*Three participants in a pharmacy setting did not answer this question 
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 In response to the question “How likely would you be to use a consumer-accessible drug information 
service?”, the overall mean response on a scale of 1–5 was an ambivalent 2.9 (mean = 3, mode = 3; see Table 2).  
It was expressed by some respondents that this type service might be beneficial to access at a time their 
pharmacy was closed.  Participants were even less receptive to the concept when asked “How likely would you 
be to use a consumer-accessible drug information service if there was a fee for the service?”, with an overall 
mean response on a scale of 1–5 of 3.5 (see Table 3). 
 
Table 3. Consumer's Willingness to Pay for Drug Information Services 
Survey Setting # Respondents Mean Median 
 
All Settings Combined 472 3.5 4 
 
     
Pharmacy 251 3.7 4 
 
     Independent 73 3.5 4 
 
     Chain Drugstore 178 3.7 4 
 
     
Non-Pharmacy 221 3.2 3 
 
*Three survey participants across all survey settings did not answer this question 
 
 
 Summarized in Table 4 are the preferred modes of access if respondents were inclined to use a 
consumer-oriented drug information service.  Finally, the types of drug-related questions consumers anticipated 
they would most commonly ask are depicted in Fig. 1. 
 
Table 4. Preferred Mode of Access 
Survey Setting % 
Telephone 35% 
Online Submission  30% 
Live Conversation  18% 
US Mail 15% 
Fax 2% 
* Four participants in a pharmacy setting 
did not answer this question 
 
 
 
Fig. 1 Types of drug information most commonly anticipated 
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IV. DISCUSSION 
A strict interpretation of the results indicates the public:  (1) does not perceive there to be a need for an 
independent consumer-oriented drug information service that is not connected in some way with their 
pharmacy-related services; (2) is ambivalent in terms of their likelihood of using a service if one were available; 
and (3) would further be less likely to use a service if a fee was involved.  These results, while somewhat 
surprising, remain valuable because absent a reason that compels them to do so, it is clear the public is not likely 
to voluntarily access the resources of a consumer-oriented drug information service.  Beyond this, the results 
perhaps raise more questions than they provide answers. 
 
 Although a measure of satisfaction was not factored into the survey, the results could indicate the 
respondents’ drug information needs were being adequately met by their pharmacist.  Alternatively, there could 
be some sampling bias related to location because more than half the surveys were taken inside a pharmacy.  
However, any effect the location had on the responses was small because, even though there was a tendency for 
non-pharmacy participants to have a greater perceived need for consumer-oriented drug information services, 
the different between settings was <10%.  Finally, cost should not have been a factor in influencing answers to 
the other questions because the question related to fee-based services was the last question asked. 
 
 Despite the survey findings, it is known that the majority of patients have unmet drug information 
needs and the lack of awareness about proper medication use and associated risk factors has been identified as 
potentially accounting for some rural health disparities.
[8]
  This is evidenced by poor medication adherence and 
issues with drug safety, problems that are only compounded in patients living in medically underserved areas.  
Several key medication-related health needs in residents in rural Arkansas have been identified.  Arkansans have 
been shown to have a high prevalence of heart disease, stroke and diabetes, chronic disease states that require 
intensive pharmacotherapy.  With respect to health maintenance, Arkansas has an adolescent immunization rate 
that is lower than the national average.  Further, rural Arkansans are more likely to struggle with low health 
literacy.[9]  Each of these represents problem areas where pharmacists can use their unique skills to enhance 
patients’ health. 
 
V. CONCLUSIONS 
Whether or not patients are in the best position to determine whether supplemental drug information is 
needed, under the scenario surveyed they would be the ones making the decision to initiate contact with the 
service described.  While these findings do not speak to whether a consumer-oriented drug information service 
would contribute to improving patient care, the survey indicates a consumer-oriented drug information 
telepharmacy service is not perceived as being needed by the public. 
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